Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    RNO.AX Gross Margin

    As of 2025-07-09, the Gross Margin of Rhinomed Ltd (RNO.AX) is 74.8%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    RNO.AX Gross Margin - Historical Value
    DateValue
    2023-06-30 74.8%
    2022-06-30 68.2%
    2021-06-30 70.7%
    2020-06-30 59.5%
    2019-06-30 66.9%
    2018-06-30 72.2%
    2017-06-30 77.7%
    2016-06-30 69.8%
    2015-06-30 55.4%
    2014-06-30 75%
    RNO.AX Gross Margin - Peers Comparison
    TickerNameValue
    506919.BOMakers Laboratories Ltd55.2%
    530477.BOVikram Thermo (India) Ltd59.4%
    531398.BOSource Natural Foods and Herbal Supplements Ltd25.5%
    AC8.AXAuscann Group Holdings Ltd100%
    ACR.AXAcrux Ltd51.1%
    AGH.AXAlthea Group Holdings Ltd60.7%
    AVE.AXAvecho Biotechnology Ltd59.3%
    BKZ.SISuntar Eco-City Ltd3.3%
    CGB.AXCann Global Ltd-13.9%
    CP1.AXCANNPAL ANIMAL THERAPEUTICS ORD-
    ECS.AXECS Botanics Holdings Ltd36.3%
    IHL.AXIncannex Healthcare Ltd48.2%
    IVX.AXInvion Ltd29.5%
    IXC.AXInvex Therapeutics Ltd7775.2%
    KILITCH.NSKilitch Drugs (India) Ltd37.2%
    KREBSBIO.NSKrebs Biochemicals and Industries Ltd87.2%
    LGP.AXLittle Green Pharma Ltd66.3%
    MKV.VNCai Lay Veterinary Pharmaceutical JSC32.7%
    MXC.AXMGC Pharmaceuticals Ltd38%
    MYX.AXMayne Pharma Group Ltd57.1%
    NYR.AXNyrada Inc-348.2%
    PAA.AXNeurizon Therapeutics Ltd79.8%
    PBP.AXProbiotec Ltd30.1%
    RCE.AXRecce Pharmaceuticals Ltd-207.6%
    VLS.AXVita Life Sciences Ltd59.4%
    WFL.AXWellfully Ltd53.1%
    Tickers added to watchlist